JP Morgan Chase’s Ultralife ULBI Stock Holding History
Bought
Maintained
Sold
Other funds holding ULBI
VWA
THC
RC
JP Morgan Chase's ULBI Position: Q2 2026 in Review
JP Morgan Chase increased its Ultralife (ULBI) stake by 6.4% in Q2 2026, buying an estimated $1.08K and bringing the position to 2,663 shares worth $16.1K. The position accounts for ﹤0.01% of the portfolio, ranked #6786.
JP Morgan Chase first reported a position in ULBI in Q3 2017 and has held it in 26 quarters since. The position peaked at $514K in Q4 2024. 52 funds tracked by Wall St. Rank hold ULBI as of Q2 2026.
- JP Morgan Chase held 2,663 shares of Ultralife worth $16.1K as of Q2 2026.
- JP Morgan Chase bought 160 Ultralife shares in Q2 2026, an estimated $1.08K.
- Ultralife made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #6786 holding.
- JP Morgan Chase first reported a position in Ultralife in Q3 2017 and has held it in 26 quarters since.
- JP Morgan Chase's Ultralife position peaked at $514K in Q4 2024.
- 52 funds tracked by Wall St. Rank held Ultralife as of Q2 2026.
Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.